Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis

Low selectivity of chemotherapy correlates with poor outcomes of cancer patients. To improve this issue, a novel agent, N-(1-[3-methoxycarbonyl-4-hydroxyphenyl]-β-carboline-3-carbonyl)-Trp-Lys-OBzl (PZL318), was reported here. The transmission electron microscopy, scanning electron microscopy, and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shan, Wang, Yuji, Wang, Feng, Wang, Yaonan, Zhang, Xiaoyi, Zhao, Ming, Feng, Qiqi, Wu, Jianhui, Zhao, Shurui, Wu, Wei, Peng, Shiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554418/
https://www.ncbi.nlm.nih.gov/pubmed/26345234
http://dx.doi.org/10.2147/IJN.S88052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554418/
https://www.ncbi.nlm.nih.gov/pubmed/26345234
http://dx.doi.org/10.2147/IJN.S88052

Ejemplares similares